Evidence map›Paper›PMID 38140072›Full record

ArticlePharmaceutics2023

Towards Antibacterial Agents: Synthesis and Biological Activity of Multivalent Amide Derivatives of Thiacalix[4]arene with Hydroxyl and Amine Groups.

Igor Shiabiev, Dmitry Pysin, Alan Akhmedov, Olga Babaeva, Vasily Babaev, Anna Lyubina, Alexandra Voloshina, Konstantin Petrov, Pavel Padnya, Ivan Stoikov

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Cyclophane-Based Dendrimers: Today and Tomorrow.Molecules (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Igor ShiabievA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya, 18, Kazan 420008, Russia.ORCID 0000-0003-4950-8078
Dmitry PysinA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya, 18, Kazan 420008, Russia.
Alan AkhmedovA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya, 18, Kazan 420008, Russia.ORCID 0000-0001-7630-7525
Olga BabaevaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, 8 Arbuzov Street, Kazan 420088, Russia.
Vasily BabaevArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, 8 Arbuzov Street, Kazan 420088, Russia.ORCID 0000-0002-3918-7031
Anna LyubinaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, 8 Arbuzov Street, Kazan 420088, Russia.
Alexandra VoloshinaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, 8 Arbuzov Street, Kazan 420088, Russia.ORCID 0000-0002-3540-8554
Konstantin PetrovArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, 8 Arbuzov Street, Kazan 420088, Russia.
Pavel PadnyaA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya, 18, Kazan 420008, Russia.ORCID 0000-0002-1924-8028
Ivan StoikovA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya, 18, Kazan 420008, Russia.ORCID 0000-0002-3019-7866
A.E. Arbuzov Institute of Organic and Physical Chemistry · RUKazan Federal University · RU

Funding

Russian Science Foundation 21-73-20067
6 · The paper itself

Abstract

Antimicrobial resistance to modern antibiotics stimulates the search for new ways to synthesize and modify antimicrobial drugs. The development of synthetic approaches that can easily change different fragments of the molecule is a promising solution to this problem. In this work, a synthetic approach was developed to obtain multivalent thiacalix[4]arene derivatives containing different number of amine and hydroxyl groups. A series of macrocyclic compounds in

Indexed as

antibacterial activityantibacterial agentcytotoxicityGram-positive bacteriasynthesisthiacalixarene

Identifiers

PMID38140072
PMCPMC10747887
OpenAlexW4389335788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.